Endometrial melanoma and cancer.

Aeterna Zentaris presents results of orally active compounds with anti-tumor results at EORTC-NCI-AACR Symposium Aeterna Zentaris Inc. Data demonstrates AEZS-129 and AEZS-132 block essential signalling pathways which donate to the proliferation and survival of malignancy cells How long does it take for antibiotics to work for a dog? . Targeting these multiple signalling pathways could result in improved treatment efficacy for such cancers as lung, colon, prostate, breast, endometrial melanoma and cancer. Both posters were provided by Irene Seipelt, Associate Director, Preclinical and Discovery Advancement at Aeterna Zentaris, through the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancers Therapeutics currently held at the Berlin Estrel Hotel and Convention Center in Berlin, Germany.